Tumor Microenvironment Sensitive Nanocarriers for Bioimaging and Therapeutics

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• The tumor microenvironment (TME) significantly influences tumor growth and progression.
• The TME exhibits unique physiological characteristics (e.g., acidic pH, hypoxia, reactive oxygen species, enzymes) distinct from normal tissues.
• Targeting the TME via nano-drug delivery systems is a key strategy for solid tumor treatment.

Purpose of the Study:

• To review recent advancements in TME-sensitive nanocarriers for enhanced tumor therapy and imaging.
• To discuss the design strategies, challenges, and considerations for fabricating TME-sensitive nanocarriers.
• To highlight the in vitro and in vivo evaluations of these nanocarriers.

Main Methods:

• Exploiting TME-specific stimuli (pH, hypoxia, ROS, enzymes) to trigger nanocarrier structural changes.
• Designing multi-stimuli-responsive nanocarriers for spatiotemporally controlled drug release.
• Fabricating and evaluating nanocarriers for targeted delivery of therapeutic and imaging agents.

Main Results:

• TME-sensitive nanocarriers facilitate targeted delivery of diagnostic and therapeutic agents.
• Smart nanocarriers responding to multiple TME stimuli enable more precise drug release.
• Recent progress shows improved efficiency in tumor therapy and imaging using these advanced nanocarriers.

Conclusions:

• TME-sensitive nanocarriers represent a significant advancement in cancer treatment strategies.
• Careful design and evaluation are crucial for developing effective nanocarrier-based therapies.
• These nanocarriers hold great potential for improving early diagnosis and effective treatment of solid tumors.